You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ustekinumab

Showing 1 - 25 of 226
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ustekinumab Intensification in Crohn's Disease

Not yet recruiting
  • Crohn Disease
  • Ustekinumab
  • (no location specified)
Jan 29, 2023

Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)

Not yet recruiting
  • Crohn's Disease
  • Chicago, Illinois
    University of Chicago Medicine
Sep 13, 2023

Transcriptomics in Treatment of Ulcerative Colitis With

Recruiting
  • Ulcerative Colitis
  • Ustekinumab
  • Athens, Attiki, Greece
    Evangelismos Hospital
Jun 8, 2023

Psoriasis, Chron's Disease Trial (Ustekinumab)

Not yet recruiting
  • Psoriasis
  • Chron's Disease
  • Ustekinumab
  • (no location specified)
Feb 2, 2023

Ustekinumab in Treatment of Crohn's Disease

Completed
  • Ustekinumab
  • +3 more
    • Wenzhou, Zhejiang, China
      SAHWenzhouMU
    May 18, 2023

    Ustekinumab Among Bio-naive Crohn's Disease in China

    Not yet recruiting
    • Crohn Disease
    • Ustekinumab
    • Hangzhou, Zhejiang, China
    • +2 more
    Oct 9, 2023

    Crohn Disease Trial in Zaventem (Ustekinumab)

    Recruiting
    • Crohn Disease
    • Ustekinumab
    • Zaventem, Belgium
      Ingrid Arijs
    Dec 13, 2022

    Healthy Volunteers Trial in Melbourne (Stelara, RT-111 (0.5mg), RT-111 (0.75mg))

    Not yet recruiting
    • Healthy Volunteers
    • Melbourne, Australia
      Nucleus Network
    Jun 5, 2023

    Ustekinumab in Active Crohn's Disease

    Completed
    • Crohn Disease
    • Evaluation of biological predictive factors of clinical response to ustekinumab
    • Pierre-Bénite, France
      Centre hospitalier Lyon Sud
    Aug 23, 2022

    Ustekinumab and Tofacitinib as Third Line Therapy inMulticenter

    Completed
    • Ulcerative Colitis
    • Milano, Italy
      Mariangela Allocca
    Feb 13, 2023

    LAD1 Trial run by the NIAID (Ustekinumab)

    Recruiting
    • LAD1
    • Ustekinumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Crohn Disease Trial (selective intensive induction therapy based on ustekinumab clinical decision-making tools)

    Not yet recruiting
    • Crohn Disease
    • selective intensive induction therapy based on ustekinumab clinical decision-making tools
    • (no location specified)
    May 6, 2023

    Primary Sjögren Syndrome Trial in Rochester (Ustekinumab)

    Completed
    • Primary Sjögren Syndrome
    • Ustekinumab
    • Rochester, New York
      University of Rochester
    Jul 6, 2022

    Children With Crohn's Disease

    Recruiting
    • Crohn's Disease
    • Ustekinumab
    • Burlington, Vermont
      ImproveCareNow, Inc.
    Aug 12, 2022

    Changes in Body Composition Under Ustekinumab in PsA

    Terminated
    • Psoriatic Arthritis
    • Bone mineral density (BMD)
    • Lille, France
      Hôpital Roger Salengro, CHU
    Oct 13, 2022

    Crohn's Disease With Ustekinumab:an Analysis Based on Imaging

    Recruiting
    • Inflammatory Bowel Diseases
    • +2 more
      • Guangzhou, Guangdong, China
        the Sixth Affiliated Hospital of Sun Yat-Sen University
      Dec 7, 2022

      Ustekinumab in Participants Suffering From Inflammatory Bowel

      Recruiting
      • Crohn Disease
      • Colitis, Ulcerative
      • Ustekinumab
      • Vandoeuvre les Nancy, France
        CHU de Nancy - Hôpital de Brabois
      Aug 17, 2022

      Bullous Pemphigoid Trial in Reims (Ustekinumab)

      Recruiting
      • Bullous Pemphigoid
      • Ustekinumab
      • Reims, France
        Damien JOLLY
      Mar 15, 2022

      Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)

      Recruiting
      • Hematologic and Lymphocytic Disorder
      • Hematopoietic and Lymphoid Cell Neoplasm
      • Placebo Administration
      • +3 more
      • Duarte, California
      • +3 more
      Dec 14, 2022

      Crohn Disease Trial in Baltimore, New York (Ustekinumab)

      Recruiting
      • Crohn Disease
      • Ustekinumab
      • Baltimore, Maryland
      • +1 more
      Jul 29, 2022

      Type 1 Diabetes Trial in Toronto, Vancouver (Ustekinumab, Placebo)

      Recruiting
      • Type 1 Diabetes Mellitus
      • Ustekinumab
      • Placebo
      • Toronto, British Columbia, Canada
      • +1 more
      Jun 3, 2022

      Symptomatic Stricturing Crohn's Disease

      Not yet recruiting
      • Crohn Disease
      • +2 more
      • Ustekinumab
      • (no location specified)
      May 22, 2022

      Juvenile Psoriatic Arthritis, Psoriasis, Arthritis, Juvenile Trial in United States (Ustekinumab)

      Recruiting
      • Juvenile Psoriatic Arthritis
      • +2 more
      • Ustekinumab
      • Los Angeles, California
      • +7 more
      Aug 17, 2022

      Ichthyosis Trial in Chicago (Ustekinumab)

      Recruiting
      • Ichthyosis
      • Ustekinumab
      • Chicago, Illinois
        Northwestern University/Lurie Children's Hospital
      Apr 19, 2022

      Crohn Disease Trial in Zaventem (Ustekinumab)

      Recruiting
      • Crohn Disease
      • Ustekinumab
      • Zaventem, Belgium
        Ingrid Arijs
      Mar 18, 2022